There's much more uranium enrichment demand than supply. This is especially true now in the West, as governments and utilities seek to wean themselves from Russian enrichment which currently supplies about 40% of enrichment to US utilities. Silex is the major partner of the Global Laser Enrichment joint venture, located in the US. Laser enrichment is more efficient and versatile than its rival technology, centrifuge cascades. GLE has signed agreements with the top 3 US nuclear utilities to work together when the tech is commercialized. Cameco is currently the junior partner in the joint venture. Cameco is the biggest non-state-owned uranium miner in the world. They also do conversion, and with the acquisition of Westinghouse they also produce fuel and build reactors. So they're involved in every part of the fuel cycle. They have the option to increase their share in GLE from 49% to 75%, which will result in a large cash infusion to Silex, and more involvement (read: funding) to GLE by Cameco, as well as bundling contracts (uranium, conversion, enrichment, fuel production sold as a package). Silex will have a smaller piece of a much bigger pie. Silex will receive a royalty in perpetuity in addition to their then junior share.
On top of that, there's their zero spin silicon technology, which could potentially make a ton of money if silicon-based quantum computing is the winning model.
- Forums
- ASX - By Stock
- Nuclear Power Related Media Thread
SLX
silex systems limited
Add to My Watchlist
2.25%
!
$4.34

There's much more uranium enrichment demand than supply. This is...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.34 |
Change
-0.100(2.25%) |
Mkt cap ! $1.033B |
Open | High | Low | Value | Volume |
$4.54 | $4.61 | $4.32 | $3.963M | 895.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16533 | $4.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.39 | 3059 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1162 | 4.310 |
1 | 338 | 4.260 |
1 | 1185 | 4.210 |
2 | 22090 | 4.200 |
1 | 1130 | 4.180 |
Price($) | Vol. | No. |
---|---|---|
4.410 | 28344 | 1 |
4.520 | 571 | 1 |
4.560 | 800 | 1 |
4.570 | 11982 | 1 |
4.580 | 25000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SLX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online